In ischemic stroke, therapeutic manipulation of brain RAS has been investigated to control blood pressure (54) and blockade of the classical RAS with ACE inhibitors and selective AT1R inhibitors (ARBs) has proven more effective than beta-blockers for secondary prevention of stroke (55). Here, AGTR1 is linked to stroke disorder.